Medical Director (Nephrology)
ICON plc
Summary
As a Medical Director at ICON, you will drive medical initiatives within project teams, guiding strategic direction and decision-making processes, and offer expert medical and scientific guidance, leveraging therapeutic expertise to inform project development.
Job description
What You Will Do
You will lead medical affairs delivery across your portfolio, setting standards and developing your team. Key responsibilities include:
- Medical Monitoring
- Providing strategic medical leadership and guidance on project teams.
- Offering expert medical and scientific consultation throughout project lifecycles.
- Ensuring compliance with ethical, legal, and regulatory standards in medical and safety monitoring activities.
- Reviewing medical data on the indication, inclusion / exclusion criteria and other medical issues to ensure our overall project deliverables are achieved
- Representing the Medical Affairs Department in business development initiatives, investigator meetings and project kick-off meetings.
- Providing operational oversight within the Medical Affairs Department as needed.
Your Profile
You will bring significant medical and clinical research expertise and a passion for driving research forward. Required qualifications and experience:
- Medical degree (MD or equivalent) with specialization in Nephrology.
- Board Certified in Internal Medicine or Nephrology
- Proven track record of medical leadership and consultation within pharmaceutical or biotechnology industries or CRO space preferred.
- Strong understanding of regulatory requirements and ethical standards in clinical research.
- Excellent communication and interpersonal skills, with the ability to represent the department effectively.
- Demonstrated ability to provide operational management in the absence of senior management.
- Experience working with phase II-III studies either in industry or as an investigator is highly preferred.
- Willingness to travel as required (approximately 10%)
Requirements
- Medical degree (MD or equivalent) with specialization in Nephrology.
- Board Certified in Internal Medicine or Nephrology
- Proven track record of medical leadership and consultation within pharmaceutical or biotechnology industries or CRO space preferred.
- Strong understanding of regulatory requirements and ethical standards in clinical research.
- Excellent communication and interpersonal skills, with the ability to represent the department effectively.
- Demonstrated ability to provide operational management in the absence of senior management.
- Experience working with phase II-III studies either in industry or as an investigator is highly preferred.
- Willingness to travel as required (approximately 10%)
Benefits
- Competitive base salary
- Performance related incentives
- Medical, dental & vision coverage
- Retirement and pension plans
- Life assurance and disability coverage
- Employee assistance programmes
- Wellbeing resources
- Learning and development opportunities
Company overview
ICON plc is a global leader in clinical research and healthcare intelligence, founded in Dublin, Ireland in 1990. As one of the world's largest contract research organizations (CROs), ICON provides comprehensive outsourced development services to pharmaceutical, biotechnology, and medical device companies worldwide. The company operates in 55 countries with approximately 41,900 employees, offering end-to-end solutions that span the entire product development lifecycle. ICON's service portfolio includes clinical research services, adaptive trials, biosimilars, commercialization and outcomes consulting, medical imaging, laboratory services, and strategic support for traditional and digital health technologies. The company specializes in therapeutic areas such as oncology, cardiovascular diseases, central nervous system disorders, rare diseases, and women's health. With its 2021 acquisition of PRA Health Sciences, ICON significantly expanded its capabilities and market position, becoming a dominant force in the global CRO industry. The company is publicly traded on NASDAQ under the ticker ICLR and reported $8.28 billion in revenue for 2024.